An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T-cell leukemia virus type 1

[1]  J. Goedert,et al.  Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1 , 2014, Retrovirology.

[2]  J. Goedert,et al.  Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1 , 2014, Retrovirology.

[3]  C. Drake,et al.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[4]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[5]  G. Freeman,et al.  PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. , 2012, The Journal of clinical investigation.

[6]  D. Bruder,et al.  Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction. , 2012, Reviews on recent clinical trials.

[7]  K. Ohashi,et al.  Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade , 2011, Veterinary research.

[8]  E John Wherry,et al.  T cell exhaustion , 2011 .

[9]  Yuetsu Tanaka,et al.  Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. , 2011, The Journal of infectious diseases.

[10]  K. Tajima,et al.  Ethnoepidemiology of HTLV‐1 related diseases: Ethnic determinants of HTLV‐1 susceptibility and its worldwide dispersal , 2011, Cancer science.

[11]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[12]  S. Rahman,et al.  Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection , 2011, The Journal of Immunology.

[13]  B. Wigdahl,et al.  Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells , 2006, Journal of NeuroVirology.

[14]  B. Wigdahl,et al.  Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation , 2004, Journal of NeuroVirology.

[15]  Katherine G. Evans,et al.  Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression. , 2010, Archives of dermatology.

[16]  F. Proietti,et al.  Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated Diseases , 2010, Clinical Microbiology Reviews.

[17]  S. Rahman,et al.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice , 2010, The Journal of Immunology.

[18]  K. Williams,et al.  Evaluation of a 12‐color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[19]  J. Herbeuval,et al.  Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. , 2010, Blood.

[20]  J. Todd,et al.  Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry , 2010, Nature Protocols.

[21]  S. Rahman,et al.  Presentation of human T cell leukemia virus type 1 (HTLV‐1) Tax protein by dendritic cells: the underlying mechanism of HTLV‐1‐associated neuroinflammatory disease , 2009, Journal of leukocyte biology.

[22]  A. Utsunomiya,et al.  Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. , 2009, Blood.

[23]  G. Vanham,et al.  IFN‐γ production in response to Tax 161–233, and frequency of CD4+ Foxp3+ and Lin− HLA‐DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV‐1‐carriers in a Peruvian population , 2009, Immunology.

[24]  B. Wigdahl,et al.  DC-SIGN Mediates Cell-Free Infection and Transmission of Human T-Cell Lymphotropic Virus Type 1 by Dendritic Cells , 2009, Journal of Virology.

[25]  T. Molina,et al.  Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. , 2009, Blood.

[26]  V. Wijewardana,et al.  Rapid Influx and Death of Plasmacytoid Dendritic Cells in Lymph Nodes Mediate Depletion in Acute Simian Immunodeficiency Virus Infection , 2009, PLoS pathogens.

[27]  Tim R Mosmann,et al.  An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. , 2009, Journal of immunological methods.

[28]  C. Tei,et al.  PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients , 2009, Leukemia.

[29]  G. Freeman,et al.  Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade , 2009, PLoS pathogens.

[30]  D. Hazuda,et al.  PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination , 2009, The Journal of Immunology.

[31]  G. Freeman,et al.  Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade , 2008, Nature.

[32]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[33]  F. Ruscetti,et al.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells , 2008, Nature Medicine.

[34]  G. Pedrazzi,et al.  Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. , 2008, Journal of hepatology.

[35]  Scott N. Mueller,et al.  Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection , 2008, The Journal of experimental medicine.

[36]  S. Shimizu,et al.  Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1 , 2007, Journal of leukocyte biology.

[37]  Y. Sun,et al.  Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells , 2007, PloS one.

[38]  B. Wigdahl,et al.  Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  G. Missale,et al.  Dysfunction and functional restoration of HCV‐specific CD8 responses in chronic hepatitis C virus infection , 2007, Hepatology.

[40]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[41]  G. Freeman,et al.  Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression , 2006, Journal of Virology.

[42]  G. Freeman,et al.  Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade , 2006, The Journal of experimental medicine.

[43]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[44]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[45]  H. Blum,et al.  Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection , 2006, Journal of Virology.

[46]  E. Murphy,et al.  Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.

[47]  N. Kadowaki,et al.  Depletion and impaired interferon‐α‐producing capacity of blood plasmacytoid dendritic cells in human T‐cell leukaemia virus type I‐infected individuals , 2004, British journal of haematology.

[48]  R. Maserati,et al.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. , 2003, Blood.

[49]  T. Sauerbruch,et al.  Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4. , 2002, Immunology letters.

[50]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[51]  A. Foussat,et al.  Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. , 2001, Blood.

[52]  M Roederer,et al.  Frequency difference gating: a multivariate method for identifying subsets that differ between samples. , 2001, Cytometry.

[53]  J. Oger,et al.  Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased. , 1999, Cellular immunology.

[54]  P. Rudge,et al.  Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. , 1992, AIDS research and human retroviruses.